Drug Class
inhaled corticosteroid and long-acting beta-2 agonist
Type
brand
Active Ingredient
fluticasone propionate and salmeterol
📋Overview
Wixela Inhub is a combination medication containing fluticasone propionate and salmeterol. It is commonly used in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The medication works by reducing inflammation in the airways and helping to keep them open, making it easier to breathe. It is typically prescribed for individuals who require ongoing control of their respiratory symptoms.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Wixela Inhub
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.